AMP-201

N/A

Report date: 2024/11/07 16:15:55

Base Information

Drug NameAMP-201
Drug Alias NameAMP-201
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAcetylcholinesterase collagenic tail peptide gene transference
TargetsAcetylcholinesterase collagenic tail peptide
Therapy Area/IndicationsMyasthenic Syndromes, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNagoya University
China Registration ClassN/A

Develop Information

Active CompaniesNagoya UniversityAmplo Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsMyasthenic Syndromes, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A